Vyera claims Qualcomm reversal supports its defence against FTC

Vyera Pharmaceuticals has said a federal appellate court’s recent Qualcomm decision supports the company’s defence against FTC claims that it violated antitrust laws.

Unlock unlimited access to all Global Competition Review content